Now Live! The “Safe Handling Dance” Video to Benefit ASHP/ONS Foundations

Share Article

Get Steppin’ to Safety! 100,000 Views Equals a Charitable Donation to Further the Safe Handling of Hazardous Drugs

News Image
working with or near hazardous drugs in healthcare settings may cause skin rashes, infertility, miscarriage, birth defects and possibly leukemia or other cancers.

You’ve heard of the Safety Dance – but what about the “Safe Handling Dance”? In recognition of National Safe Handling Awareness Month (April), Carmel Pharma, Inc. and the oncology healthcare staff at Novant Health System’s Presbyterian Cancer Center in Charlotte, NC, have teamed up to create the "Safe Handling Dance” video to further education surrounding the proper handling of hazardous drugs, such as chemotherapy.

Fun and informative, the video is intended to show how the team of professionals at the Presbyterian Cancer Center approached implementation of a multi-disciplinary safe handling awareness program with an upbeat, “can-do” attitude. To help promote widespread awareness of safe handling best practices, Carmel Pharma is proud make a charitable donation to the American Society of Health-System Pharmacists (ASHP) Foundation and the Oncology Nursing Society (ONS) Foundation if the YouTube video reaches 100,000 views by July 4, 2010.

To view the video and help support future safe handling education, please visit http://www.step2safety.wordpress.com or Carmel Pharma’s YouTube channel at http://www.youtube.com/user/carmelpharmausa.

The Importance of Safe Handling
In 2004, the National Institute for Occupational Safety and Health (NIOSH) released an alert stating that “working with or near hazardous drugs in healthcare settings may cause skin rashes, infertility, miscarriage, birth defects and possibly leukemia or other cancers.” Further evidence to support the need to take action in this area may be found below:

  • The World Health Organization predicts a 50 percent increase of cancer cases over the next 20 years; this, combined with more potent chemotherapy drugs – as well as an increase in the use of hazardous drugs to treat non-malignant illnesses – will continue to elevate risk of exposure.
  • Two separate studies investigating the toxicity in healthcare personnel who handle cytotoxic (hazardous) drugs revealed a 40-50 percent increased risk for miscarriage. A total of 7094 pregnancies of 2976 pharmacy and nursing staff were examined.
  • A national survey conducted by the Environmental Working Group, the American Nurses Association, Health Care Without Harm and the Environmental Health Education Center at the University of Maryland School of Nursing showed that there are links between nurses’ occupational exposure to hazardous drugs and the health problems they develop such as cancer, asthma, miscarriages and children’s birth defects.

About Safe Handling Awareness Month
Now in its second year, National Safe Handling Awareness Month (April) was petitioned to raise awareness of the occupational risks associated with handling hazardous drugs and educate healthcare providers on the U.S. guidelines and safety measures that may be taken to prevent hazardous drug exposure. As the highlight of National Safe Handling Awareness Month, National Safe Handling Awareness Day (April 20) brings together national and regional educational opportunities collectively aimed at preserving the health and wellbeing of the oncology healthcare professionals who devote their lives to helping others. National Safe Handling Awareness Month and Day are officially endorsed by the International Society of Oncology Pharmacy Practitioners (ISOPP) and are officially sponsored by Carmel Pharma, the maker of the PhaSeal® System – today’s only clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. For additional details on National Safe Handling Awareness Month/Day, visit http://www.carmelpharmausa.com/aware5 or call 866-487-9250.

About Carmel Pharma (the maker of the PhaSeal System)
Carmel Pharma AB, headquartered in Gothenberg, Sweden, is the manufacturer of the PhaSeal System for the safe handling of hazardous drugs. PhaSeal is more than a system for the safe handling of hazardous drugs. It’s the only clinically proven closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent, peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the “Gold Standard” in safe handling, PhaSeal’s airtight Expansion Chamber and leakproof Double Membrane connections prevent exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy Practitioners (ISOPP) definition of a true CSTD. Its streamlined design and universally-compatible components make the system easy to use from preparation and administration to waste disposal.

In the United States, PhaSeal is distributed by an U.S. affiliate office, Carmel Pharma, Inc., located in Columbus, OH. The PhaSeal System has been in use in the U.S. since 1998 and implemented in more than 1000 cancer facilities, infusion centers and private practices, including M.D. Anderson and Texas Children’s in Houston, TX; City of Hope in Duarte, CA; Dana Farber Cancer Institute in Boston, MA; SwedishAmerican Hospital in Rockford, IL; and Johns Hopkins University in Baltimore, MD, just to name a few. For more information on Carmel Pharma or the PhaSeal System, please visit http://www.phaseal.com or email info(at)carmelpharmausa(dot)com. To request additional product details, high-resolution imagery, story ideas and expert references, or to learn more about the topic of safe handling from today’s clinical thought leaders, please visit http://www.carmelpharmausa.com/media or contact Emily Frydendal at 614-318-2635.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Emily Frydendal